Leading companies move to Veeva cloud applications to accelerate
product development and commercialization
PLEASANTON, Calif.--(BUSINESS WIRE)--
Veeva
Systems (NYSE:VEEV) today announced increasing numbers of medical
devices and diagnostics (MD&D) companies are adopting Veeva
Vault applications to streamline content and data management in
clinical, quality, and commercial. Veeva now has more than 65 medical
devices and diagnostics customers using Veeva Vault, including 11 of the
world’s top 25 medical devices companies. Organizations are using Veeva
Vault to meet evolving regulatory guidelines and drive greater
efficiency in their operations.
Veeva Vault provides unified suites of cloud applications for medical
devices and diagnostics companies to manage regulated content and data
throughout the product lifecycle. Veeva Vault for MD&D includes Vault
eTMF and Vault
CTMS for clinical; Vault
QMS and Vault
QualityDocs for quality; Vault
MedComms for medical; and Vault
PromoMats for commercial.
“Changing regulations are prompting organizations to adopt advanced
content and data management applications to improve collaboration and
ensure compliance,” said Melonie Warfel, vice president of medical
devices and diagnostics at Veeva. “Veeva Vault helps customers drive
consistency across business processes and be more agile in a rapidly
evolving marketplace.”
Companies now need to find new ways to compete globally and bring
innovative products to market faster. With Veeva Vault, organizations
can streamline end-to-end processes from product development through
commercialization.
“Veeva Vault allows us to quickly adapt to changing compliance and
business requirements by providing tighter control over data and
documents and real-time visibility across teams,” said Andrew Tummon,
director of global clinical affairs at Integra LifeSciences. “We’ve been
able to unify key business processes with Veeva Vault so we’re more
agile, easily pivoting direction to prevent delays.”
Veeva also announced today that more than 180 life sciences companies
have adopted Veeva
Vault Quality applications to streamline quality management across
their organizations and with external partners. Read the Vault
Quality news to learn more.
Also, join more than 1,300 life sciences professionals and experts at
the upcoming Veeva
R&D Summit in Philadelphia, September 16-18. Hear how Veeva
Vault helps medical devices and diagnostics companies ensure global
consistency and speed time to market. Learn more, register, and view the
full agenda at veeva.com/R&DSummit.
Additional Information
For more on Veeva Vault for medical devices and diagnostics, visit: veeva.com/MD&D
Connect
with Veeva on LinkedIn: linkedin.com/company/veeva-systems
Follow
@veevasystems on Twitter: twitter.com/veevasystems
Like
Veeva on Facebook: facebook.com/veevasystems
About Veeva Systems
Veeva Systems Inc. is a leader in cloud-based software for the global
life sciences industry. Committed to innovation, product excellence, and
customer success, Veeva has more than 650 customers, ranging from the
world's largest pharmaceutical companies to emerging biotechs. Veeva is
headquartered in the San Francisco Bay Area, with offices throughout
North America, Europe, Asia, and Latin America. For more information,
visit veeva.com.
Forward-looking Statements
This release contains forward-looking statements, including the market
demand for and acceptance of Veeva’s products and services, the results
from use of Veeva’s products and services, and general business
conditions, particularly in the life sciences industry. Any
forward-looking statements contained in this press release are based
upon Veeva’s historical performance and its current plans, estimates,
and expectations, and are not a representation that such plans,
estimates, or expectations will be achieved. These forward-looking
statements represent Veeva’s expectations as of the date of this press
announcement. Subsequent events may cause these expectations to change,
and Veeva disclaims any obligation to update the forward-looking
statements in the future. These forward-looking statements are subject
to known and unknown risks and uncertainties that may cause actual
results to differ materially. Additional risks and uncertainties that
could affect Veeva’s financial results are included under the captions,
“Risk Factors” and “Management’s Discussion and Analysis of Financial
Condition and Results of Operations,” in the company’s filing on Form
10-Q for the period ended July 31, 2018. This is available on the
company’s website at veeva.com
under the Investors section and on the SEC’s website at sec.gov.
Further information on potential risks that could affect actual results
will be included in other filings Veeva makes with the SEC from time to
time.
View source version on businesswire.com:
https://www.businesswire.com/news/home/20180912005364/en/
Veeva Systems
Roger Villareal, 925-264-8885
roger.villareal@veeva.com
or
Lisa
Barbadora, 610-420-3413
pr@veeva.com
Source: Veeva Systems